vs
NEOGEN CORP（NEOG）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
NEOGEN CORP的季度营收约是LiveRamp Holdings, Inc.的1.1倍（$224.7M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -7.1%，领先25.9%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs -2.8%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs -0.9%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NEOG vs RAMP — 直观对比
营收规模更大
NEOG
是对方的1.1倍
$212.2M
营收增速更快
RAMP
高出11.4%
-2.8%
净利率更高
RAMP
高出25.9%
-7.1%
两年增速更快
RAMP
近两年复合增速
-0.9%
损益表 — Q2 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $212.2M |
| 净利润 | $-15.9M | $39.9M |
| 毛利率 | 47.5% | 71.9% |
| 营业利润率 | -2.4% | 18.6% |
| 净利率 | -7.1% | 18.8% |
| 营收同比 | -2.8% | 8.6% |
| 净利润同比 | 96.5% | 255.7% |
| 每股收益（稀释后） | $-0.07 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGRAMP
| Q4 25 | $224.7M | $212.2M | ||
| Q3 25 | $209.2M | $199.8M | ||
| Q2 25 | $225.4M | $194.8M | ||
| Q1 25 | $221.0M | $188.7M | ||
| Q4 24 | $231.3M | $195.4M | ||
| Q3 24 | $217.0M | $185.5M | ||
| Q2 24 | $236.8M | $176.0M | ||
| Q1 24 | $228.8M | $171.9M |
净利润NEOGRAMP
| Q4 25 | $-15.9M | $39.9M | ||
| Q3 25 | $36.3M | $27.4M | ||
| Q2 25 | $-612.3M | $7.7M | ||
| Q1 25 | $-10.9M | $-6.3M | ||
| Q4 24 | $-456.3M | $11.2M | ||
| Q3 24 | $-12.6M | $1.7M | ||
| Q2 24 | $-5.4M | $-7.5M | ||
| Q1 24 | $-2.0M | $-5.4M |
毛利率NEOGRAMP
| Q4 25 | 47.5% | 71.9% | ||
| Q3 25 | 45.4% | 70.2% | ||
| Q2 25 | 41.2% | 70.1% | ||
| Q1 25 | 49.9% | 69.3% | ||
| Q4 24 | 49.0% | 71.9% | ||
| Q3 24 | 48.4% | 72.4% | ||
| Q2 24 | 47.9% | 70.6% | ||
| Q1 24 | 51.1% | 72.2% |
营业利润率NEOGRAMP
| Q4 25 | -2.4% | 18.6% | ||
| Q3 25 | -7.7% | 10.7% | ||
| Q2 25 | -271.1% | 3.7% | ||
| Q1 25 | 2.4% | -6.1% | ||
| Q4 24 | -197.8% | 7.5% | ||
| Q3 24 | 1.0% | 4.0% | ||
| Q2 24 | 5.5% | -3.0% | ||
| Q1 24 | 5.3% | -8.3% |
净利率NEOGRAMP
| Q4 25 | -7.1% | 18.8% | ||
| Q3 25 | 17.4% | 13.7% | ||
| Q2 25 | -271.6% | 4.0% | ||
| Q1 25 | -4.9% | -3.3% | ||
| Q4 24 | -197.3% | 5.7% | ||
| Q3 24 | -5.8% | 0.9% | ||
| Q2 24 | -2.3% | -4.3% | ||
| Q1 24 | -0.9% | -3.1% |
每股收益（稀释后）NEOGRAMP
| Q4 25 | $-0.07 | $0.62 | ||
| Q3 25 | $0.17 | $0.42 | ||
| Q2 25 | $-2.82 | $0.12 | ||
| Q1 25 | $-0.05 | $-0.10 | ||
| Q4 24 | $-2.10 | $0.17 | ||
| Q3 24 | $-0.06 | $0.03 | ||
| Q2 24 | $-0.02 | $-0.11 | ||
| Q1 24 | $-0.01 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $962.3M |
| 总资产 | $3.4B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEOGRAMP
| Q4 25 | $145.3M | $403.4M | ||
| Q3 25 | $138.9M | $376.9M | ||
| Q2 25 | $129.0M | $371.1M | ||
| Q1 25 | $127.7M | $420.8M | ||
| Q4 24 | $140.2M | $384.3M | ||
| Q3 24 | $120.5M | $348.4M | ||
| Q2 24 | $170.9M | $342.7M | ||
| Q1 24 | $168.4M | $368.9M |
股东权益NEOGRAMP
| Q4 25 | $2.1B | $962.3M | ||
| Q3 25 | $2.1B | $943.8M | ||
| Q2 25 | $2.1B | $947.8M | ||
| Q1 25 | $2.7B | $948.9M | ||
| Q4 24 | $2.7B | $957.7M | ||
| Q3 24 | $3.1B | $932.1M | ||
| Q2 24 | $3.1B | $951.9M | ||
| Q1 24 | $3.1B | $949.1M |
总资产NEOGRAMP
| Q4 25 | $3.4B | $1.3B | ||
| Q3 25 | $3.4B | $1.2B | ||
| Q2 25 | $3.4B | $1.2B | ||
| Q1 25 | $4.0B | $1.3B | ||
| Q4 24 | $4.1B | $1.3B | ||
| Q3 24 | $4.5B | $1.2B | ||
| Q2 24 | $4.5B | $1.2B | ||
| Q1 24 | $4.6B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | — |
| 自由现金流经营现金流 - 资本支出 | $7.8M | — |
| 自由现金流率自由现金流/营收 | 3.5% | — |
| 资本支出强度资本支出/营收 | 5.2% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | — |
8季度趋势，按日历期对齐
经营现金流NEOGRAMP
| Q4 25 | $19.4M | — | ||
| Q3 25 | $10.9M | $57.4M | ||
| Q2 25 | $16.4M | $-15.8M | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $40.3M | $45.1M | ||
| Q3 24 | $-17.9M | $55.6M | ||
| Q2 24 | $26.7M | $-9.3M | ||
| Q1 24 | $-30.2M | — |
自由现金流NEOGRAMP
| Q4 25 | $7.8M | — | ||
| Q3 25 | $-13.1M | $56.8M | ||
| Q2 25 | $349.0K | $-16.2M | ||
| Q1 25 | $-13.4M | — | ||
| Q4 24 | $23.1M | $44.8M | ||
| Q3 24 | $-56.3M | $55.4M | ||
| Q2 24 | $2.5M | $-9.6M | ||
| Q1 24 | $-62.3M | — |
自由现金流率NEOGRAMP
| Q4 25 | 3.5% | — | ||
| Q3 25 | -6.3% | 28.4% | ||
| Q2 25 | 0.2% | -8.3% | ||
| Q1 25 | -6.1% | — | ||
| Q4 24 | 10.0% | 22.9% | ||
| Q3 24 | -26.0% | 29.8% | ||
| Q2 24 | 1.1% | -5.4% | ||
| Q1 24 | -27.2% | — |
资本支出强度NEOGRAMP
| Q4 25 | 5.2% | 0.1% | ||
| Q3 25 | 11.5% | 0.3% | ||
| Q2 25 | 7.1% | 0.2% | ||
| Q1 25 | 14.9% | 0.2% | ||
| Q4 24 | 7.4% | 0.1% | ||
| Q3 24 | 17.7% | 0.1% | ||
| Q2 24 | 10.2% | 0.1% | ||
| Q1 24 | 14.0% | 1.0% |
现金转化率NEOGRAMP
| Q4 25 | — | — | ||
| Q3 25 | 0.30× | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
RAMP
暂无分部数据
